Team builds viruses to combat harmful 'biofilms'

They have already successfully demonstrated one such virus, and thanks to a "plug and play" library of "parts" believe that many more could be custom-designed to target different species or strains of bacteria.

The work, reported in the July 3 Proceedings of the National Academy of Sciences, helps vault synthetic biology from an abstract science to one that has proven practical applications. "Our results show we can do simple things with synthetic biology that have potentially useful results," says first author Timothy Lu, a doctoral student in the Harvard-MIT Division of Health Sciences and Technology.

Bacterial biofilms can form almost anywhere, even on your teeth if you don't brush for a day or two. When they accumulate in hard to reach places such as the insides of food processing machines or medical catheters, however, they become persistent sources of infection.

These bacteria excrete a variety of proteins, polysaccharides, and nucleic acids that together with other accumulating materials form an extracellular matrix, or in Lu's words, a "slimy layer," that encases the bacteria. Traditional remedies such as antibiotics are not as effective on these bacterial biofilms as they are on free-floating bacteria. In some cases, antibiotics even encourage bacterial biofilms to form.

Lu and senior author James Collins, professor of biomedical engineering at BU, aim to eradicate these biofilms using bacteriophage, tiny viruses that attack bacteria. Phage have long been used in Eastern Europe and Russia to treat infection.

For a phage to be effective against a biofilm, it must both attack the strain of bacteria in the film and degrade the film itself. Recently, a different group of researchers discovered several phages in sewage that meet both criteria because, among other things, they carry enzymes capable of degrading a biofilm's extracellular matrix.

This discovery led Lu and Collins to consider engineering phages to carry enzymes with similar capabilities. Why? Finding a good naturally occurring combination for a given industrial or medical problem is difficult. Plus, "people don't want to dig through sewage to find these phages," says Lu.

So Collins and Lu defined a modular system that allows engineers to design phages to target specific biofilms. As a proof of concept, they used their strategy to engineer T7, an Escherichia coli-specific phage, to express dispersin B (DspB), an enzyme known to disperse a variety of biofilms.

To test the engineered T7 phage, the team cultivated E. coli biofilms on plastic pegs. They found that their engineered phage eliminated 99.997% of the bacterial biofilm cells, an improvement by two orders of magnitude over the phage's nonengineered cousin.

The team's modular strategy can be thought of as a "plug and play" library, says Collins. "The library could contain different phages that target different species or strains of bacteria, each constructed using related design principles to express different enzymes."

Creating such a library may soon be feasible with new technologies for synthesizing genes quickly and cheaply. "We hope in a few years, it will be easy to create libraries of phage that we know have a good chance of working a priori because we know so much about their inner-workings," says Lu.

Synthetic biology also makes it possible to control the timing of when a gene is expressed in an organism. For instance, Lu inserted the DspB genes into a precise location in the T7 genome so that the phage would strongly express it during infection rather than before or after. Such control was possible because T7 was extremely well characterized by other researchers such as MIT synthetic biologist Drew Endy, an assistant professor of biological engineering.

Though phages are not approved for use in humans in the United States, recently the FDA approved a phage cocktail to treat Listeria monocytogenes on lunchmeat. This makes certain applications, such as cleaning products that include phages to clear slime in food processing plants, more immediately promising. Another potential application: phage-containing drugs for use in livestock in exchange for or in combination with antibiotics.

Source: MIT

Newly identified enzyme treats deadly bacterial infections in mice
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on. Now, with an uptick in antibiotic-resistant bacteria reaching alarming proportions, Rockefeller University scientists have identified an enzyme produced in viruses (called bacteriophages) that could stop these one-celled powerhouses dead in their tracks.
Biologists surprised to find parochial bacterial viruses
Biologists examining ecosystems similar to those that existed on Earth more than 3 billion years ago have made a surprising discovery: Viruses that infect bacteria are sometimes parochial and unrelated to their counterparts in other regions of the globe.
Hidden interactions between predators and prey: evolution causes cryptic dynamics in ecology
When the populations of two species oscillate together (for example, predators and prey), it’s a good bet that they are tightly coupled ecologically. A famous example is the Canadian lynx and snowshoe hare, documented in the trapping records of the Hudson’s Bay Company. But is the opposite also true" If the prey’s population doesn’t fluctuate while the predator’s does, can we assume they are not tightly linked in the food web?
New viruses to treat bacterial diseases
Viruses found in the River Cam in Cambridge, famous as a haunt of students in their punts on long, lazy summer days, could become the next generation of antibiotics, according to scientists speaking today at the Society for General Microbiology’s 161st Meeting at the University of Edinburgh, UK.
Probing Question: Why are some strains of E. coli resistant to antibiotics?
Although they're among the simplest organisms, bacteria are some of the most creative life forms on earth. Just ask molecular biologist Chobi DebRoy, director of Penn State's Gastroenteric Disease Center. "We receive bacterial samples from all over the world -- from veterinary clinics, medical centers, zoos, farms," DebRoy said. Her lab works to identify disease-causing strains of E. coli and to determine whether they are antibiotic-resistant.
Different strategies underlie the ecology of microbial invasions
Infectious disease can play a key role in mediating the outcome of competition between rival groups, as seen in the effects of disease-bearing conquistadors in the New World--or, on a much smaller ecological scale, the ability of bacteria to spread their viruses to competing bacteria.
Success comes at a cost, even for phages
As many a mother may tell you, expending the energy necessary to raise a clutch of kids can shave years off one's life. Trade-offs between reproductive success and survival have been demonstrated for a wide variety of organisms, in keeping with life history theory. In a new study published in the open-access journal PLoS Biology, Marianne De Paepe and Franзois Taddei asked whether these trade-offs extend to viruses, which are not--by some definitions--even alive.
Quantum Dot Method Rapidly Identifies Bacteria
A rapid method for detecting and identifying very small numbers of diverse bacteria, from anthrax to E. coli, has been developed by scientists from the National Cancer Institute (NCI) and National Institute of Standards and Technology (NIST). Described in the March 28 issue of Proceedings of the National Academy of Sciences, the work could lead to the development of handheld devices for accelerated identification of biological weapons and antibiotic-resistant or virulent strains of bacteria—situations where speed is essential.

Team builds viruses to combat harmful 'biofilms'

Related stories:

News discussion: